Americans are increasing their awareness of GLP-1 medications such as Ozempic and Wegovy, according to a survey.
Interest in GLP-1 medications, like Ozempic and Wegovy, which are used for weight loss, has seen a notable rise among U.S. adults in recent years, a recent study reveals. A YouGov poll, published on Friday, indicates that at least 80% of participants have heard “a little” about these drugs, which are primarily utilized to manage […]
Diabetes and weight-loss medications might also help with arthritis symptoms.
The Benefits of GLP-1 Drugs Extend Beyond Diabetes and Weight Loss GLP-1 drugs, known for mimicking a hormone that regulates blood sugar, might have effects beyond managing diabetes and aiding in weight loss. Experts suggest that medications like semaglutide (Ozempic, Wegovy) and tilzepatide (Munjaro, Zepbound) could offer relief for those suffering from rheumatoid arthritis (RA). […]
Discovery as two FDA-approved medications are shown to reverse Alzheimer’s, including recovering memory
In a remarkable breakthrough, scientists have found that two existing drugs not only slow Alzheimer’s disease but can actually reverse its effects and improve memory in mice. What’s even more intriguing is that both medications are already FDA-approved—though mainly for cancer treatment. The research team initially explored how Alzheimer’s disrupts gene activity in brain cells. […]
The FDA needs to take action against hazardous counterfeit weight-loss medications.
Hope in the Fight Against Obesity For the first time, there’s a glimmer of hope in tackling obesity. Recent data from the National Center for Health Statistics at the CDC indicates that adult obesity rates in the US might finally stabilize after years of annual increases since at least 2011. Obesity, long understood to be […]
Common cancer medications found to potentially treat Alzheimer’s disease
New Research Suggests Cancer Drugs May Help Alzheimer’s Patients Recent research indicates that two cancer medications might slow down or even reverse symptoms of Alzheimer’s disease. Researchers from the University of California, San Francisco (UCSF) delved into how dementia influences gene expression, essentially turning genes on or off, as stated in a university press release. […]
Missouri Attorney General files a lawsuit against Planned Parenthood for supposedly misrepresenting the risks of abortion medications.
Missouri has initiated legal action against a reproductive health organization, alleging that it misrepresents the risks associated with abortion medications. This lawsuit, filed by Attorney General Andrew Bailey, claims that Planned Parenthood suggests that these drugs are safer than many commonly used medications, which the state argues is false and breaches consumer protection laws. Bailey […]
Children’s National Hospital in DC Stops Prescribing Transgender Medications
Children’s Hospital in Washington, DC Discontinues Gender-Affirming Medications A children’s hospital in Washington, DC has announced plans to stop prescribing medications aimed at helping children transition to the opposite sex. The hospital made this information clear on its website. The Gender Development Programs section includes updates for both new and current patients, indicating a concern […]
Trump warns of 200% tariffs on medications
President Trump has mentioned imposing tariffs on imported pharmaceuticals, possibly hitting rates as high as 200%. However, he indicated that any actual taxation might not take effect for over a year. “They’ll get a very high rate of tariffs, like 200%,” Trump stated during a cabinet meeting on Tuesday, yet he acknowledged a delay before […]
Stylists notice more hair thinning in people using weight loss medications.
Impact of GLP-1 Medications on Hair Loss Side effects from GLP-1 medications can vary, with one notable outcome—often overlooked—is hair loss or thinning. Some hair stylists have reported an uptick in clients who mention experiencing hair loss during their weight loss journeys. Ashlie Di Matto, who runs Ashley Lauren Beauty Lounge in Westchester, New York, […]
Patients with obesity and additional health issues are the best candidates for weight-loss medications.
Weight loss medications are gaining traction, and it’s estimated that the global market for these therapies could hit $150 billion by 2035. Drugs like GLP-1 agonists—semaglutide-based options such as Ozempic, Wegovy, Mounjaro, and Zepbound—are primarily designed to treat type 2 diabetes and manage obesity. Interestingly, recent research suggests additional benefits that doctors are beginning to […]